Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Samanidis (Athens, Greece), K. Perreas (Athens, Greece), C. Verikokos (Athens, Greece), K. Kontzoglou (Athens, Greece), D. Perrea (Athens, Greece), P. Demertzis (Athens, Greece), G. Hardavella (Athens, Greece). Potential biomarkers in patients with chronic obstructive pulmonary disease (COPD). 566

Member's Comments

No comment yet.

Related content which might interest you: The state of patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2007; 30: Suppl. 51, 547s Year: 2007 Therapeutic approaches in the chronic obstructive (COPD) pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 472s Year: 2002 Bronchiectasis impact outcomes in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Pathogenic therapy of patients with chronic obstructive pulmonary diseases (COPD) Source: Annual Congress 2007 - New insights into the treatment of COPD Year: 2007 Correlates of osteoporosis in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Predictors of arrhythmias in patients with chronic obstructive pulmonary disease (COPD). Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 Investigation of the role of miRNAs as a biomarker in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2012 - COPD inflammation and genes Year: 2012 Candidate gene associations in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - The biology of smoking and COPD Year: 2008 The impact of using different symptom-based exacerbation algorithms in patients with COPD Source: Eur Respir J 2011; 37: 1260-1268 Year: 2011 Predictive factors of endothelial function in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Prognosis in COPD Year: 2008 Enalapril in the management of patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2003; 22: Suppl. 45, 241s Year: 2003 Optimal assessment and management of chronic obstructive pulmonary disease (COPD) Source: Guideline 1995 Year: 1995 Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)? Source: Eur Respir J 2001; 18: Suppl. 33, 241s Year: 2001 The characteristic of chronic renal dysfunction in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Functional and inflammatory bowel diseases in patients with chronic obstructive pulmonary disease (COPD). Source: International Congress 2019 – Advances in clinical management of COPD Year: 2019 Large airways remodeling in chronic obstructive pulmonary disease (COPD) patients Source: Annual Congress 2008 - Pathophysiology of respiratory diseases Year: 2008 Predictive factors of arterial stiffness in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pathophysiology of COPD Year: 2008 Reasons for hospitalisation patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 473s Year: 2002 Chronic obstructive pulmonary disease (COPD) patients with bronchiectasis: clinical features? Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Seasonal variations and outcomes in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2010 - The nursing challenges and strategies when caring for patients with chronic lung disease Year: 2010